IBDEI1GY ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24551,1,3,0)
 ;;=3^Pyelonephritis
 ;;^UTILITY(U,$J,358.3,24551,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,24551,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,24552,0)
 ;;=J30.9^^121^1221^198
 ;;^UTILITY(U,$J,358.3,24552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24552,1,3,0)
 ;;=3^Rhinitis, allergic
 ;;^UTILITY(U,$J,358.3,24552,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,24552,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,24553,0)
 ;;=B86.^^121^1221^200
 ;;^UTILITY(U,$J,358.3,24553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24553,1,3,0)
 ;;=3^Scabies
 ;;^UTILITY(U,$J,358.3,24553,1,4,0)
 ;;=4^B86.
 ;;^UTILITY(U,$J,358.3,24553,2)
 ;;=^108096
 ;;^UTILITY(U,$J,358.3,24554,0)
 ;;=M00.9^^121^1221^204
 ;;^UTILITY(U,$J,358.3,24554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24554,1,3,0)
 ;;=3^Septic Joint/Arthritis
 ;;^UTILITY(U,$J,358.3,24554,1,4,0)
 ;;=4^M00.9
 ;;^UTILITY(U,$J,358.3,24554,2)
 ;;=^5009693
 ;;^UTILITY(U,$J,358.3,24555,0)
 ;;=B02.9^^121^1221^208
 ;;^UTILITY(U,$J,358.3,24555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24555,1,3,0)
 ;;=3^Shingles/zoster
 ;;^UTILITY(U,$J,358.3,24555,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,24555,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,24556,0)
 ;;=J01.90^^121^1221^209
 ;;^UTILITY(U,$J,358.3,24556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24556,1,3,0)
 ;;=3^Sinusitis, acute
 ;;^UTILITY(U,$J,358.3,24556,1,4,0)
 ;;=4^J01.90
 ;;^UTILITY(U,$J,358.3,24556,2)
 ;;=^5008127
 ;;^UTILITY(U,$J,358.3,24557,0)
 ;;=J32.9^^121^1221^210
 ;;^UTILITY(U,$J,358.3,24557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24557,1,3,0)
 ;;=3^Sinusitis, chronic
 ;;^UTILITY(U,$J,358.3,24557,1,4,0)
 ;;=4^J32.9
 ;;^UTILITY(U,$J,358.3,24557,2)
 ;;=^5008207
 ;;^UTILITY(U,$J,358.3,24558,0)
 ;;=A49.01^^121^1221^149
 ;;^UTILITY(U,$J,358.3,24558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24558,1,3,0)
 ;;=3^Methicillin Susceptible Staphylococcus Aureus Infection
 ;;^UTILITY(U,$J,358.3,24558,1,4,0)
 ;;=4^A49.01
 ;;^UTILITY(U,$J,358.3,24558,2)
 ;;=^5000235
 ;;^UTILITY(U,$J,358.3,24559,0)
 ;;=R61.^^121^1221^223
 ;;^UTILITY(U,$J,358.3,24559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24559,1,3,0)
 ;;=3^Sweats/Night Sweats
 ;;^UTILITY(U,$J,358.3,24559,1,4,0)
 ;;=4^R61.
 ;;^UTILITY(U,$J,358.3,24559,2)
 ;;=^331970
 ;;^UTILITY(U,$J,358.3,24560,0)
 ;;=A51.0^^121^1221^224
 ;;^UTILITY(U,$J,358.3,24560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24560,1,3,0)
 ;;=3^Syphilis genital, primary
 ;;^UTILITY(U,$J,358.3,24560,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,24560,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,24561,0)
 ;;=A51.5^^121^1221^225
 ;;^UTILITY(U,$J,358.3,24561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24561,1,3,0)
 ;;=3^Syphilis,Early Latent
 ;;^UTILITY(U,$J,358.3,24561,1,4,0)
 ;;=4^A51.5
 ;;^UTILITY(U,$J,358.3,24561,2)
 ;;=^266730
 ;;^UTILITY(U,$J,358.3,24562,0)
 ;;=A52.8^^121^1221^226
 ;;^UTILITY(U,$J,358.3,24562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24562,1,3,0)
 ;;=3^Syphilis,Late Latent
 ;;^UTILITY(U,$J,358.3,24562,1,4,0)
 ;;=4^A52.8
 ;;^UTILITY(U,$J,358.3,24562,2)
 ;;=^266779
 ;;^UTILITY(U,$J,358.3,24563,0)
 ;;=A52.9^^121^1221^228
 ;;^UTILITY(U,$J,358.3,24563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24563,1,3,0)
 ;;=3^Syphilis,Tertiary
 ;;^UTILITY(U,$J,358.3,24563,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,24563,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,24564,0)
 ;;=A52.3^^121^1221^227
 ;;^UTILITY(U,$J,358.3,24564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24564,1,3,0)
 ;;=3^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,24564,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,24564,2)
 ;;=^5000298
